TY - JOUR
T1 - Novel pathogenic UQCRC2 variants in a female with normal neurodevelopment
AU - Haidar, Lea Abou
AU - Harris, Robert C.
AU - Pachnis, Panayotis
AU - Chen, Hongli
AU - Gotway, Garrett K.
AU - Ni, Min
AU - DeBerardinis, Ralph J.
N1 - Publisher Copyright:
© 2023 Cold Spring Harbor Laboratory Press. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Electron transport chain (ETC) disorders are a group of rare, multisystem diseases caused by impaired oxidative phosphorylation and energy production. Deficiencies in complex III (CIII), also known as ubiquinol–cytochrome c reductase, are particularly rare in humans. Ubiquinol–cytochrome c reductase core protein 2 (UQCRC2) encodes a subunit of CIII that plays a crucial role in dimerization. Several pathogenic UQCRC2 variants have been identified in patients presenting with metabolic abnormalities that include lactic acidosis, hyperammonemia, hypoglycemia, and organic aciduria. Almost all previously reported UQCRC2-deficient patients exhibited neurodevelopmental involvement, including developmental delays and structural brain anomalies. Here, we describe a girl who presented at 3 yr of age with lactic acidosis, hyperammonemia, and hypoglycemia but has not shown any evidence of neurodevelopmental dysfunction by age 15. Whole-exome sequencing revealed compound heterozygosity for two novel variants in UQCRC2: c.1189G>A; p.Gly397Arg and c.437T>C; p.Phe146Ser. Here, we discuss the patient’s clinical presentation and the likely pathogenicity of these two missense variants.
AB - Electron transport chain (ETC) disorders are a group of rare, multisystem diseases caused by impaired oxidative phosphorylation and energy production. Deficiencies in complex III (CIII), also known as ubiquinol–cytochrome c reductase, are particularly rare in humans. Ubiquinol–cytochrome c reductase core protein 2 (UQCRC2) encodes a subunit of CIII that plays a crucial role in dimerization. Several pathogenic UQCRC2 variants have been identified in patients presenting with metabolic abnormalities that include lactic acidosis, hyperammonemia, hypoglycemia, and organic aciduria. Almost all previously reported UQCRC2-deficient patients exhibited neurodevelopmental involvement, including developmental delays and structural brain anomalies. Here, we describe a girl who presented at 3 yr of age with lactic acidosis, hyperammonemia, and hypoglycemia but has not shown any evidence of neurodevelopmental dysfunction by age 15. Whole-exome sequencing revealed compound heterozygosity for two novel variants in UQCRC2: c.1189G>A; p.Gly397Arg and c.437T>C; p.Phe146Ser. Here, we discuss the patient’s clinical presentation and the likely pathogenicity of these two missense variants.
UR - http://www.scopus.com/inward/record.url?scp=85178951609&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85178951609&partnerID=8YFLogxK
U2 - 10.1101/mcs.a006295
DO - 10.1101/mcs.a006295
M3 - Article
C2 - 37709555
AN - SCOPUS:85178951609
SN - 2373-2873
VL - 9
JO - Cold Spring Harbor Molecular Case Studies
JF - Cold Spring Harbor Molecular Case Studies
IS - 4
ER -